Last updated 2026-07-26
- Raised $33M Series B led by Section 32, Feb 2022
- Raised $14M Series C, Mar 2024
- Raised $8.5M Series A led by Debiopharm Group, Jun 2020
Total raised
$60.5M
Last: Undisclosed Round 2024-04
Stage
Series B
Founded
2017
Headcount
65
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Nucleai is an AI-powered spatial biology company that analyzes tissue images to identify predictive biomarkers for precision oncology. The company's technology leverages advanced geospatial AI methods to analyze complex cellular interactions, enabling a deeper understanding of disease mechanisms and biomarker identification. Nucleai's platform supports drug discovery and development by providing insights from pathology slides to accelerate the development of life-saving treatments and diagnostics, particularly for cancer and gastrointestinal diseases. They partner with pharmaceutical companies, biopharmaceutical firms, and clinical research institutions.
Funding history · 4 rounds · $60.5M total
2024-03
C Round
$14.0M
Section 32Grove VenturesSanofi VenturesFosun RZ CapitalVertex Ventures IsraelDebiopharm Innovation Fund
2022-02
B Round
$33.0M
★ Section 32★ Grove Ventures★ Sanofi Ventures★ Fosun RZ Capital★ Debiopharm Group★ Vertex Ventures Israel
2020-06
A Round
$8.5M
★ Debiopharm GroupGrove VenturesVertex Ventures Israel
2018-02
Seed
$5.0M
★ Brian Cooper★ Nir Kalkstein★ Grove Ventures★ Vertex Ventures Israel
Headcount over time
From 14 (2018-08) to 71 (2026-03) · +57 (+407%) · 22 points · source: Finder history + radar grounding
Q&A
- What is Nucleai's primary focus?
- Nucleai is an AI-powered spatial biology company that analyzes tissue images to identify predictive biomarkers for precision oncology, supporting drug discovery and development.
- When was Nucleai founded?
- Nucleai was founded in July 2017.
- Which investors participated in Nucleai's Series B funding round?
- In March 2022, Nucleai raised a B Round of $33,000,000, with lead investors Section 32 and Sanofi Ventures.
- What is the total amount of funding Nucleai has raised to date?
- Nucleai has raised a total of $75,000,000.
- How many employees does Nucleai currently have?
- Nucleai currently has 65 employees, falling within the 51-200 employee bucket.
- What was a recent partnership announced by Nucleai?
- In June 2024, Nucleai and Proscia partnered to integrate predictive biomarker solutions.
- Did Nucleai experience any layoffs recently?
- In June 2024, Nucleai laid off 15% of its employees.
- What was a strategic collaboration announced by Nucleai in April 2024?
- In April 2024, Nucleai and GoPath Diagnostics announced a strategic collaboration to provide integrated AI-powered digital pathology solutions for clinical research and diagnostic applications.
Team · 3
Avi Veidman
Founder · Co-founder & CEO
Lotan Chorev
Founder · Co-founder & VP R&D
Eliron Amir
Founder · Co-founder & COO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceMachine LearningComputer VisionData StorageCloudPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersLaboratories
Business model
B2B
Highlights
1 PatentsVerified
Tags
bioconvergencecancer-diagnosticshealthcare-providersmachine-learningdiagnosticsoncologycancerdigital-healthcaredeep-learningartificial-intelligencecomputer-visionprecision-medicinemedical-technologieshospitalsimagingbiomarkerssoftware-platformcloud-basedlaboratoriesdecision-supportpharmaceuticalspharma-companiesimmunotherapyclinical-trials
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | nucleai.ai/ |
|---|---|
| linkedin.com/company/25166605 | |
| YouTube | youtube.com/channel/UCDs2VIzHSJZ5ehWsG6bqcAw |
Identifiers & details
| Former names | nuclai |
|---|---|
| Founded | 2017-7 |
| Employees (exact) | 65 |
| Offices | Chicago |
Radar intelligence
Patents
| EPO | 22 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | nucleai.ai |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515742096 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-11-07 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 3 — charge (2), people (1) |
| Registered address | עין זיתים 4 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-31 | סילוק שעבוד |
| 2025-12-30 | רישום שעבוד |
| 2025-11-06 | עדכון בעלי תפקידים |